Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion For Cancer Related Fatigue
NCT03996265Phase 3Active, not recruiting
- Sponsor
- University of Rochester Cancer Center NCORP Research Base
- Start
- Jun 2019
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion in cancer-related fatigue (CRF), sponsored by University of Rochester Cancer Center NCORP Research Base. Started Jun 2019; status: active, not recruiting.
02
Drugs
bupropion
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT03996265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03996265.